SCHEMBL21175879

SCHEMBL21175879

Cc1ccc(C(O)c2ccc(-c3noc(C(F)(F)F)n3)cc2)nc1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 19/20 0.47
HDAC6 Q9UBN7 12/20 0.47
HDAC1 Q13547 5/20 0.47
HDAC8 Q9BY41 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22566950 1.00 HDAC4 (0.47) HDAC4HDAC6HDAC1HDAC8
SCHEMBL22566951 1.00 HDAC4 (0.47) HDAC4HDAC6HDAC1HDAC8
SCHEMBL29675281 1.00 HDAC4 (0.47) HDAC4HDAC6HDAC1HDAC8
SCHEMBL24529097 0.86 HDAC6 (0.47) HDAC4HDAC6HDAC1HDAC8
SCHEMBL22566958 0.86 HDAC6 (0.47) HDAC4HDAC6HDAC1HDAC8
SCHEMBL22566947 0.86 HDAC6 (0.47) HDAC4HDAC6HDAC1HDAC8
SCHEMBL19743617 0.81 HDAC6 (0.55) HDAC4HDAC6HDAC1HDAC8
SCHEMBL21175652 0.80 HDAC4 (0.48) HDAC4HDAC6HDAC1HDAC8
SCHEMBL21175653 0.79 HDAC4 (0.47) HDAC4HDAC6HDAC1
SCHEMBL21175645 0.79 HDAC4 (0.47) HDAC4HDAC6HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220194907-A1 PROCESS FOR THE PREPARATION OF MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2022-06-23 US disclosed
US-20220194907-A1 PROCESS FOR THE PREPARATION OF MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2022-06-23 US disclosed
US-11026427-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2021-06-08 US disclosed
US-11026427-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2021-06-08 US disclosed
US-20190223441-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-07-25 US disclosed
US-20190223441-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190223441-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES PRF1, NOX3, NOX1 HDAC4 1433/4885HDAC6 612/4885HDAC1 526/4885
US-11026427-B2 Microbiocidal oxadiazole derivatives PRF1, NOX3, NOX1 HDAC4 1433/4885HDAC6 612/4885HDAC1 526/4885
US-20220194907-A1 PROCESS FOR THE PREPARATION OF MICROBIOCIDAL OXADIAZOLE DERIVATIVES CYP51A1, MPO, NOX5 HDAC4 1241/4885HDAC6 540/4885HDAC1 747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.